GENERIC NAME OF THE MEDICINAL PRODUCT:
Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/400mg (Glucotaj-ZET)
Glibenclamide and Metformin Hydrochloride Tablets USP 5mg/500mg (Glucotaj-ZET)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film-coated tablet contains:
Glibenclamide……………………….2.5mg
Metformin Hydrochloride………………….500mg
Excipients…………………………………………...q.s.
b) Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/400mg
Each film-coated tablet contains:
Glibenclamide………………………...2.5mg
Metformin Hydrochloride…………………...400mg
Excipients……………………………………………q.s.
c) Glibenclamide and Metformin Hydrochloride Tablets USP 5mg/500mg
Each film-coated tablet contains:
Glibenclamide………………………...5mg
Metformin Hydrochloride……………...…...500mg
Excipients …………………………………………... q.s.
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
ANY UNUSED PRODUCT OR WASTE MATERIAL SHOULD BE DISPOSED OF IN ACCORDANCE WITH LOCAL REQUIREMENTS.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.
Attach dispensing label as per end county.
Glibenclamide and Metformin Hydrochloride Tablets USP Technical Specification:
| Product Name: |
Glibenclamide + Metformin Hydrochloride Tablets USP |
| Brand Name: | Glucotaj-ZET |
| Strength: | 2.5mg/500mg/, 2.5mg/400mg, 5mg/500mg |
| Dosage Form: | Tablets |
| Route of Administration: | Via Oral Route |
| Packing: | 30s, 90s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-diabetic, sulfonylureas. |
| Indication: | This combination medication is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. |
| Storage: | Store at room temperature between 15 and 30 degrees C (59- and 86-degrees F). Protect from moisture and light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/500mg (Glucotaj-ZET)
- Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/400mg (Glucotaj-ZET)
- Glibenclamide and Metformin Hydrochloride Tablets USP 5mg/500mg (Glucotaj-ZET)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
a) Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/500mg
Each film-coated tablet contains:
Glibenclamide……………………….2.5mg
Metformin Hydrochloride………………….500mg
Excipients……………………………………………q.s.
b) Glibenclamide and Metformin Hydrochloride Tablets USP 2.5mg/400mg
Each film-coated tablet contains:
Glibenclamide…………………………2.5mg
Metformin Hydrochloride……………………400mg
Excipients……………………………………………q.s.
c) Glibenclamide and Metformin Hydrochloride Tablets USP 5mg/500mg
Each film-coated tablet contains:
Glibenclamide…………………………5mg
Metformin Hydrochloride……………………500mg
Excipients …………………………………………… q.s.
THERAPEUTIC INDICATIONS:
- Treatment of type 2 diabetes in adults, as replacement for previous combination therapy with metformin and glibenclamide in patients whose glycaemia is stable and well-controlled.
CAUTION & WARNING:
- CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
Any unused product or waste material should be disposed of in accordance with local requirements. - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
- Storage: Keep the bottle tightly closed in order to protect from moisture. must be stored in a cool, dry place, away from sunlight and moisture.
- Dosage:As directed by the Physician.
| Attach dispensing label as per end county. |






